NASDAQ:CUTR - Cutera Stock Price, News, & Analysis

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Cutera declared that its Board of Directors has initiated a share repurchase program on Tuesday, August 8th 2017, which allows the company to buyback $25,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to buy up to 6.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's management believes its stock is undervalued.

Cutera, Inc. (NASDAQ:CUTR) issued its quarterly earnings results on Tuesday, August, 7th. The medical device company reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.18 by $0.06. The medical device company had revenue of $42.55 million for the quarter, compared to analysts' expectations of $41.50 million. Cutera had a return on equity of 10.21% and a net margin of 15.67%. View Cutera's Earnings History.

Cutera is scheduled to release their next quarterly earnings announcement on Tuesday, November, 6th 2018. View Earnings Estimates for Cutera.

Cutera updated its FY18 earnings guidance on Tuesday, August, 7th. The company provided EPS guidance of $0.50-0.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.05. The company issued revenue guidance of $178-181 million, compared to the consensus revenue estimate of $178.58 million.

4 Wall Street analysts have issued 12-month price targets for Cutera's shares. Their forecasts range from $45.00 to $60.00. On average, they anticipate Cutera's stock price to reach $52.50 in the next year. This suggests a possible upside of 78.0% from the stock's current price. View Analyst Price Targets for Cutera.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cutera.

Some companies that are related to Cutera include AxoGen (AXGN), Natus Medical (BABY), Viewray (VRAY), Electrocore (ECOR), BioLife Solutions (BLFS), Vision Sciences (CGNT), Rockwell Medical (RMTI), Semler Scientific (SMLR), Helius Medical Technologies (HSDT), Fonar (FONR), Second Sight Medical Products (EYES), Zynex (ZYXI), Viveve Medical (VIVE), Edap Tms (EDAP) and IRIDEX (IRIX).

Cutera's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (13.93%), Renaissance Technologies LLC (7.20%), Gamco Investors INC. ET AL (4.28%), Partner Fund Management L.P. (3.52%), Gabelli Funds LLC (2.95%) and Peregrine Capital Management LLC (2.69%). Company insiders that own Cutera stock include David A Gollnick, David B Apfelberg, Gregory A Barrett, J Daniel Plants, James A Reinstein, Larry Laber, Miguel Pardos, Ronald J Santilli and Timothy J Oshea. View Institutional Ownership Trends for Cutera.

CUTR stock was sold by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Renaissance Technologies LLC, Federated Investors Inc. PA, Russell Investments Group Ltd., BlackRock Inc., Martingale Asset Management L P, Bank of New York Mellon Corp and Bank of New York Mellon Corp. Company insiders that have sold Cutera company stock in the last year include David A Gollnick, David B Apfelberg, James A Reinstein, Larry Laber, Miguel Pardos and Timothy J Oshea. View Insider Buying and Selling for Cutera.

CUTR stock was acquired by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Point72 Asset Management L.P., Eagle Asset Management Inc., American Century Companies Inc., Cortina Asset Management LLC, Partner Fund Management L.P., TD Asset Management Inc. and AMS Capital Ltda. Company insiders that have bought Cutera stock in the last two years include Gregory A Barrett and James A Reinstein. View Insider Buying and Selling for Cutera.

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CUTR stock can currently be purchased for approximately $29.50.

Cutera has a market capitalization of $415.80 million and generates $151.49 million in revenue each year. The medical device company earns $29.99 million in net income (profit) each year or $0.77 on an earnings per share basis. Cutera employs 367 workers across the globe.

The official website for Cutera is http://www.cutera.com.

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]